Immunohistochemical detection of leukemia inhibitory factor after focal cerebral ischemia in rats

Shigeaki Suzuki, Kortaro Tanaka, Shigeru Nogawa, Daisuke Ito, Tomohisa Dembo, Arifumi Kosakai, Yasuo Fukuuchi

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The cytokine leukemia inhibitory factor (LIF) modulates neuronal function during development and promotes neuronal survival after peripheral nerve injury, but little is known about LIF expression after cerebral ischemia. In the present study, the localization of LIF protein was immunohistochemically examined in rats after 3.5, 12, 24, 48, and 96 hours of reperfusion following 1.5 hours of middle cerebral artery occlusion (MCAO) induced by the intraluminal suture method. Double-staining immunohistochemistry with microtubule-associated protein-2 (MAP2), glial fibrillary acidic protein (GFAP), lectin histochemistry, and interleukin (IL) 6 was also performed. The sham group and immunosorption test did not show any clear LIF immunoreactivity. Definite LIF immunoreactivity was first detected after 12 hours of reperfusion in each of the brain regions examined: ischemic core, periinfarct region, and contralateral cortex. However, expression of LIF was most prominent in the periinfarct region at each time point, peaked at 24 hours, and then gradually declined until 96 hours of reperfusion. Some LIF-positive neurons in the periinfarct region expressed IL-6. At 96 hours of reperfusion, GFAP-labeled astrocytes around the infarct core also expressed LIF protein. Induction of LIF mRNA and protein was also confirmed by reverse transcription polymerase chain reaction and western blot analysis, respectively. These findings suggest that LIF expression in ischemically threatened neurons may reflect a repair or defense mechanism against the ischemic insult.

Original languageEnglish
Pages (from-to)661-668
Number of pages8
JournalJournal of Cerebral Blood Flow and Metabolism
Volume20
Issue number4
Publication statusPublished - 2000

Fingerprint

Leukemia Inhibitory Factor
Brain Ischemia
Reperfusion
Glial Fibrillary Acidic Protein
Interleukin-6
Neurons
Peripheral Nerve Injuries
Proteins
Microtubule-Associated Proteins
Middle Cerebral Artery Infarction
Lectins
Astrocytes
Sutures
Reverse Transcription
Western Blotting
Immunohistochemistry
Staining and Labeling
Cytokines

Keywords

  • Astrocyte
  • Focal ischemia
  • Immunohistochemistry
  • Interleukin-6
  • Leukemia inhibitory factor
  • Neuron

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)
  • Endocrinology, Diabetes and Metabolism

Cite this

Immunohistochemical detection of leukemia inhibitory factor after focal cerebral ischemia in rats. / Suzuki, Shigeaki; Tanaka, Kortaro; Nogawa, Shigeru; Ito, Daisuke; Dembo, Tomohisa; Kosakai, Arifumi; Fukuuchi, Yasuo.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 20, No. 4, 2000, p. 661-668.

Research output: Contribution to journalArticle

Suzuki, Shigeaki ; Tanaka, Kortaro ; Nogawa, Shigeru ; Ito, Daisuke ; Dembo, Tomohisa ; Kosakai, Arifumi ; Fukuuchi, Yasuo. / Immunohistochemical detection of leukemia inhibitory factor after focal cerebral ischemia in rats. In: Journal of Cerebral Blood Flow and Metabolism. 2000 ; Vol. 20, No. 4. pp. 661-668.
@article{12f297cde2f3470188fc69f3a0173407,
title = "Immunohistochemical detection of leukemia inhibitory factor after focal cerebral ischemia in rats",
abstract = "The cytokine leukemia inhibitory factor (LIF) modulates neuronal function during development and promotes neuronal survival after peripheral nerve injury, but little is known about LIF expression after cerebral ischemia. In the present study, the localization of LIF protein was immunohistochemically examined in rats after 3.5, 12, 24, 48, and 96 hours of reperfusion following 1.5 hours of middle cerebral artery occlusion (MCAO) induced by the intraluminal suture method. Double-staining immunohistochemistry with microtubule-associated protein-2 (MAP2), glial fibrillary acidic protein (GFAP), lectin histochemistry, and interleukin (IL) 6 was also performed. The sham group and immunosorption test did not show any clear LIF immunoreactivity. Definite LIF immunoreactivity was first detected after 12 hours of reperfusion in each of the brain regions examined: ischemic core, periinfarct region, and contralateral cortex. However, expression of LIF was most prominent in the periinfarct region at each time point, peaked at 24 hours, and then gradually declined until 96 hours of reperfusion. Some LIF-positive neurons in the periinfarct region expressed IL-6. At 96 hours of reperfusion, GFAP-labeled astrocytes around the infarct core also expressed LIF protein. Induction of LIF mRNA and protein was also confirmed by reverse transcription polymerase chain reaction and western blot analysis, respectively. These findings suggest that LIF expression in ischemically threatened neurons may reflect a repair or defense mechanism against the ischemic insult.",
keywords = "Astrocyte, Focal ischemia, Immunohistochemistry, Interleukin-6, Leukemia inhibitory factor, Neuron",
author = "Shigeaki Suzuki and Kortaro Tanaka and Shigeru Nogawa and Daisuke Ito and Tomohisa Dembo and Arifumi Kosakai and Yasuo Fukuuchi",
year = "2000",
language = "English",
volume = "20",
pages = "661--668",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Immunohistochemical detection of leukemia inhibitory factor after focal cerebral ischemia in rats

AU - Suzuki, Shigeaki

AU - Tanaka, Kortaro

AU - Nogawa, Shigeru

AU - Ito, Daisuke

AU - Dembo, Tomohisa

AU - Kosakai, Arifumi

AU - Fukuuchi, Yasuo

PY - 2000

Y1 - 2000

N2 - The cytokine leukemia inhibitory factor (LIF) modulates neuronal function during development and promotes neuronal survival after peripheral nerve injury, but little is known about LIF expression after cerebral ischemia. In the present study, the localization of LIF protein was immunohistochemically examined in rats after 3.5, 12, 24, 48, and 96 hours of reperfusion following 1.5 hours of middle cerebral artery occlusion (MCAO) induced by the intraluminal suture method. Double-staining immunohistochemistry with microtubule-associated protein-2 (MAP2), glial fibrillary acidic protein (GFAP), lectin histochemistry, and interleukin (IL) 6 was also performed. The sham group and immunosorption test did not show any clear LIF immunoreactivity. Definite LIF immunoreactivity was first detected after 12 hours of reperfusion in each of the brain regions examined: ischemic core, periinfarct region, and contralateral cortex. However, expression of LIF was most prominent in the periinfarct region at each time point, peaked at 24 hours, and then gradually declined until 96 hours of reperfusion. Some LIF-positive neurons in the periinfarct region expressed IL-6. At 96 hours of reperfusion, GFAP-labeled astrocytes around the infarct core also expressed LIF protein. Induction of LIF mRNA and protein was also confirmed by reverse transcription polymerase chain reaction and western blot analysis, respectively. These findings suggest that LIF expression in ischemically threatened neurons may reflect a repair or defense mechanism against the ischemic insult.

AB - The cytokine leukemia inhibitory factor (LIF) modulates neuronal function during development and promotes neuronal survival after peripheral nerve injury, but little is known about LIF expression after cerebral ischemia. In the present study, the localization of LIF protein was immunohistochemically examined in rats after 3.5, 12, 24, 48, and 96 hours of reperfusion following 1.5 hours of middle cerebral artery occlusion (MCAO) induced by the intraluminal suture method. Double-staining immunohistochemistry with microtubule-associated protein-2 (MAP2), glial fibrillary acidic protein (GFAP), lectin histochemistry, and interleukin (IL) 6 was also performed. The sham group and immunosorption test did not show any clear LIF immunoreactivity. Definite LIF immunoreactivity was first detected after 12 hours of reperfusion in each of the brain regions examined: ischemic core, periinfarct region, and contralateral cortex. However, expression of LIF was most prominent in the periinfarct region at each time point, peaked at 24 hours, and then gradually declined until 96 hours of reperfusion. Some LIF-positive neurons in the periinfarct region expressed IL-6. At 96 hours of reperfusion, GFAP-labeled astrocytes around the infarct core also expressed LIF protein. Induction of LIF mRNA and protein was also confirmed by reverse transcription polymerase chain reaction and western blot analysis, respectively. These findings suggest that LIF expression in ischemically threatened neurons may reflect a repair or defense mechanism against the ischemic insult.

KW - Astrocyte

KW - Focal ischemia

KW - Immunohistochemistry

KW - Interleukin-6

KW - Leukemia inhibitory factor

KW - Neuron

UR - http://www.scopus.com/inward/record.url?scp=0034006311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034006311&partnerID=8YFLogxK

M3 - Article

C2 - 10779010

AN - SCOPUS:0034006311

VL - 20

SP - 661

EP - 668

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 4

ER -